Leadership
|
Kevin W. Massengill, Managing DirectorKevin W. Massengill is the Managing Director of Massengill Advisory LLC a Florida-based business consultancy and family office managing investments in hard assets and private equity.
|
Massengill is also the Executive Chairman of Meraglim Holdings Corporation, a Delaware company. An AI investment holding company, Meraglim® created the world's leading Raven Predictive Analytics® a patent-pending enterprise SaaS combining AI, complexity science and human intelligence for institutional investors and corporate leaders.
Massengill is also the Chairman of the Board for six different acquisition focused QLA investment companies: a Dutch NEWCO (construction), Northstar Security Holdings, Nutraceutical Holdings, RecordAI (healthcare technology), United Pain Clinics, and Vernal Partners, Inc. (healthcare facilities).
A retired U.S. Army officer and former senior defense executive with Fortune 500 companies Raytheon (NYSE: RTX) and Leidos (NYSE: LDOS), Massengill also served as a managing director of Silver Leaf Partners, a boutique New York investment bank.
Massengill has previously served as Chairman of the Board for the Leidos (NYSE: LDOS) operating businesses in Australia, Saudi Arabia and the United Kingdom, a member of the Overseas Schools Advisory Council for the U.S. Department of State - D.C., a Non Executive Board Director for GrowthGate Capital, a private equity buy out firm in Dubai, and as Chairman of the Board of Trustees for the American Community School - Abu Dhabi.
Massengill holds an MA in Near Eastern Studies from Princeton University, a BA in Russian Area Studies from the University of Missouri-Columbia where he was a Distinguished Military Graduate and awarded a US Army Top 5% Fellowship. He has completed the International Directors Program at INSEAD Fontainebleau, the Program on Negotiation for Senior Executives at Harvard Law School and held FINRA Series 7 and Series 63 licenses.
Massengill is also the Chairman of the Board for six different acquisition focused QLA investment companies: a Dutch NEWCO (construction), Northstar Security Holdings, Nutraceutical Holdings, RecordAI (healthcare technology), United Pain Clinics, and Vernal Partners, Inc. (healthcare facilities).
A retired U.S. Army officer and former senior defense executive with Fortune 500 companies Raytheon (NYSE: RTX) and Leidos (NYSE: LDOS), Massengill also served as a managing director of Silver Leaf Partners, a boutique New York investment bank.
Massengill has previously served as Chairman of the Board for the Leidos (NYSE: LDOS) operating businesses in Australia, Saudi Arabia and the United Kingdom, a member of the Overseas Schools Advisory Council for the U.S. Department of State - D.C., a Non Executive Board Director for GrowthGate Capital, a private equity buy out firm in Dubai, and as Chairman of the Board of Trustees for the American Community School - Abu Dhabi.
Massengill holds an MA in Near Eastern Studies from Princeton University, a BA in Russian Area Studies from the University of Missouri-Columbia where he was a Distinguished Military Graduate and awarded a US Army Top 5% Fellowship. He has completed the International Directors Program at INSEAD Fontainebleau, the Program on Negotiation for Senior Executives at Harvard Law School and held FINRA Series 7 and Series 63 licenses.
Next Step:
If you are the owner of a business with $5m to $50m in revenue and you are looking for a safe pair of hands to protect your legacy, brand and employees, you have nothing to lose by having a quick conversation. Click the button below to schedule a call.
Follow Kevin Massengill at...
"Gold is not a drug that cures the disease but merely a symbol of the flight from dishonesty - a symbol of independence, honest money and permanence." - Anthony Deden
